Recherche
-
Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression
(British Journal of Haematology. vol. 188, n° 6, pp. 935–944, 2020)Article de revue -
MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms
(BMC Cancer. vol. 18, n° 1, pp. 1098, 2018-12)Article de revue -
Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloproliferative neoplasms (FIM) study
(American Journal of Hematology. vol. 93, n° 4, pp. E84–E86, 2018-08)Article de revueAccès réservé -
Quantification of the Mutant CALR Allelic Burden by Digital PCR
(The Journal of Molecular Diagnostics. vol. 18, n° 1, pp. 68–74, 2016-01)Article de revue -
Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study.
(Leukemia, 2020-07-21)Article de revue -
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.
(Blood Advances. vol. 5, n° 5, pp. 1442-1451, 2021-03-09)Article de revue -
Clonal haematopoiesis and cardiovascular diseases: A growing relationship
(Archives of cardiovascular diseases, 2021-03-10)Article de revueLibre accès -
Absence of JAK2V617F Mutated Endothelial Colony-Forming Cells in Patients With JAK2V617F Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis
(HemaSphere. vol. 4, n° 3, pp. e364, 2020-06)Article de revueLibre accès -
The Expression of Myeloproliferative Neoplasm-Associated Calreticulin Variants Depends on the Functionality of ER-Associated Degradation
(Cancers. vol. 11, n° 12, 2019-12)Article de revueLibre accès -
Description of a knock-in mouse model of JAK2V617F MPN emerging from a minority of mutated hematopoietic stem cells
(Blood. vol. 134, n° 26, pp. 2383–2387, 2019-12)Article de revueAccès réservé